Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), Neogen (NEOG) and Community Health (CYH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medtronic (MDT), Neogen (NEOG) and Community Health (CYH).

Claim 55% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Medtronic (MDT)

Citi analyst Joanne Wuensch reiterated a Buy rating on Medtronic yesterday and set a price target of $110.00. The company’s shares closed last Friday at $83.32.

According to TipRanks.com, Wuensch is a 3-star analyst with an average return of 1.0% and a 50.8% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Establishment Labs Holdings, and Bausch + Lomb Corporation. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medtronic with a $106.35 average price target, a 27.4% upside from current levels. In a report issued on April 13, RBC Capital also maintained a Buy rating on the stock with a $118.00 price target.

See today’s best-performing stocks on TipRanks >>

Neogen (NEOG)

William Blair analyst Brandon Vazquez maintained a Hold rating on Neogen today. The company’s shares closed last Friday at $9.54, close to its 52-week low of $8.31.

According to TipRanks.com, Vazquez is a 1-star analyst with an average return of -3.2% and a 33.1% success rate. Vazquez covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Irhythm Technologies, and Edwards Lifesciences. ;'>

Currently, the analyst consensus on Neogen is a Moderate Buy with an average price target of $12.00, a 28.3% upside from current levels. In a report issued on April 20, TipRanks – xAI also reiterated a Hold rating on the stock with a $9.50 price target.

Community Health (CYH)

Wells Fargo analyst Stephen Baxter maintained a Sell rating on Community Health yesterday and set a price target of $2.00. The company’s shares closed last Friday at $2.72, close to its 52-week low of $2.53.

According to TipRanks.com, Baxter is a 1-star analyst with an average return of -0.1% and a 45.9% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Concentra Group Holdings Parent, Inc., BrightSpring Health Services, Inc., and Molina Healthcare. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Community Health with a $3.54 average price target, implying a 41.6% upside from current levels. In a report issued on April 22, TipRanks – Anthropic also downgraded the stock to Sell with a $3.00 price target.

Read More on MDT:

Disclaimer & DisclosureReport an Issue

• Medtronic announces milestones for Sphere-9, Sphere 360 catheters
• Medtronic announces FDA granted Breakthrough Device Designations to Sphere-9
• Medtronic price target lowered to $95 from $108 at Jefferies
• Medtronic: Portfolio Streamlining and Diabetes Spin-Off Benefits Offset by Lower Growth Outlook and Valuation Compression, Justifying Hold Rating
• Medtronic price target lowered to $90 from $104 at UBS